Effects and interactions of LH and LHRH agonist on testicular morphology and function in hypophysectomized rats
- 1 January 1986
- journal article
- research article
- Published by Bioscientifica in Reproduction
- Vol. 76 (1) , 175-192
- https://doi.org/10.1530/jrf.0.0760175
Abstract
Summary. The effects of single or combined daily treatment with an LHRH agonist and low or high doses of LH upon the testes of adult hypophysectomized rats were studied for up to 2 weeks in which changes in testicular histology, particularly the interstitial tissue, were examined by morphometry and related to functional assessment of the Leydig cells in vivo and in vitro. Compared to saline-treated controls, LHRH agonist treatment did not alter testis volume or the composition of the seminiferous epithelium or any of the interstitial tissue components although serum testosterone and in-vitro testosterone production by isolated Leydig cells were significantly reduced. With 2 μg LH for treatment, testis volume was increased, spermatogenesis was qualitatively normal, total Leydig cell volume was increased, serum testosterone values were initially elevated but subsequently declined and in-vitro testosterone production was enhanced. Testis volume with 20 μg LH treatment was unchanged compared to saline treatment, the seminiferous epithelium exhibited severe disruption but total Leydig cell volume was greatly increased due to interstitial cell hyperplasia. This group showed elevated serum testosterone concentrations and major increases in testosterone production in vitro. Treatment with LHRH agonist with either dose of LH resulted in reduced testis volume, moderate to very severe focal spermatogenic disruption and increased total Leydig cell volume although serum testosterone values and in-vitro testosterone production were markedly reduced compared to control rats. It is concluded that, in the absence of the pituitary, LHRH agonist fails to disrupt spermatogenesis and the previously described antitesticular action of LHRH agonists in intact rats is therefore dependent upon the presence of LH, which alone or in combination with LHRH agonist, may focally disrupt spermatogenesis in hypophysectomized rats whereas the Leydig cells undergo hyperplasia. The findings show that impairment of spermatogenesis is accompanied by alterations of the interstitial tissue and suggest that communication between these two compartments is involved in the regulation of testicular function.This publication has 16 references indexed in Scilit:
- Reversible Induction of Azoospermia in Rhesus Monkeys by Constant Infusion of a Gonadotropin-Releasing Hormone Agonist Using Osmotic MinipumpsJournal of Clinical Endocrinology & Metabolism, 1983
- INABILITY OF CONTINUOUS LONG-TERM ADMINISTRATION OF D-NAL(2)6-LHRH TO ABOLISH FERTILITY IN MALE-RATS1983
- Mice Are Insensitive to the Antitesticular Effects of Luteinizing Hormone-Releasing Hormone Agonists*Endocrinology, 1983
- Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal MenNew England Journal of Medicine, 1981
- GONADOTROPIN-RELEASING HORMONE ANALOG AND TESTOSTERONE SYNERG1STICALLY INHIBIT SPERMATOGENESISEndocrinology, 1981
- Gonadotropin-Releasing Hormone and Its Agonist Inhibit Testicular Luteinizing Hormone Receptor and Steroidogenesis in Immature and Adult Hypophysectomized Rats*Endocrinology, 1980
- Increase in Leydig Cell Number in Testes of Adult Rats Treated Chronically with an Excess of Human Chorionic GonadotropinBiology of Reproduction, 1980
- Chronic Effects of [D-Trp6,Pro9-NEt]Luteinizing Hormone-Releasing Factor on Reproductive Processes in the Male Rat*Endocrinology, 1979
- INHIBITION OF SPERMATOGENESIS IN THE RAT BY TREATMENT WITH [D-Ala6,DES-GLY-NH210]LHRH ETHYLAMIDEEndocrinology, 1978
- A radioimmunoassay for testosterone in various biological fluids without chromatographyThe Journal of Steroid Biochemistry and Molecular Biology, 1978